Related Experiment Video
Updated: Aug 5, 2025

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
SOX10 Inhibits T Cell Recognition by Inducing Expression of the Immune Checkpoint Molecule PD-L1 in A375 Melanoma
Kenta Sasaki1,2, Yoshihiko Hirohashi3, Kenji Murata1
1Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Background/Aim:
Malignant melanoma is a fatal skin cancer and is among the most immunogenic malignancies expressing melanoma-differentiation antigens and neoantigens. SRY-related HMG-box 10 (SOX10) is a transcription factor and a neural-crest differentiation marker that is used as a diagnostic marker for melanoma whilst playing a role in melanoma initiation through activation of the SOX10-MITF axis. SOX10 was shown to play a role in melanoma initiation by inducing expression of immune checkpoint molecules (e.g., HVEM and CEACAM1). In this study, we aimed to investigate the relationship between SOX10 and the expression an immune checkpoint molecule, programmed death-1 ligand 1 (PD-L1).
Materials And Methods:
SOX10 overexpression and knockdown was performed using SOX10 gene transfection and SOX10 siRNA transfection into A375 melanoma cells. PD-L1 expression was assessed by flow cytometry and western blotting. T cell response was evaluated using NY-ESO-1 specific TCR-transduced T (TCR-T) cells by IFNγ ELISPOT assay.
Results:
SOX10 overexpression increased the expression of PD-L1, whereas SOX10 knockdown, using siRNA, decreased its expression. IFNγ ELISPOT assay revealed that overexpression of SOX10 decreased the susceptibility of cells to NY-ESO-1-specific TCR-T cells.
Conclusion:
SOX10 has a role in the intrinsic immune suppressive mechanisms of melanoma through expression of PD-L1.
Insights
SRY-related HMG-box 10 (SOX10) drives immune suppression in melanoma by increasing programmed death-1 ligand 1 (PD-L1) expression. This SOX10-PD-L1 axis reduces T cell effectiveness against melanoma cells.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Malignant melanoma is an immunogenic cancer.
- SOX10 is a transcription factor crucial for melanoma initiation and a diagnostic marker.
- SOX10 influences melanoma immune evasion by regulating immune checkpoint molecules.
Purpose of the Study:
- To investigate the relationship between SOX10 and programmed death-1 ligand 1 (PD-L1) expression in melanoma.
- To understand SOX10's role in melanoma's immune suppressive mechanisms.
Main Methods:
- SOX10 overexpression and knockdown were achieved via gene and siRNA transfection in A375 melanoma cells.
- PD-L1 expression was quantified using flow cytometry and western blotting.
- T cell response was assessed via IFNγ ELISPOT assay using NY-ESO-1 specific TCR-transduced T cells.
Main Results:
- SOX10 overexpression led to increased PD-L1 expression.
- SOX10 knockdown resulted in decreased PD-L1 expression.
- SOX10 overexpression reduced melanoma cell susceptibility to NY-ESO-1 specific TCR-T cells.
Conclusions:
- SOX10 contributes to melanoma's intrinsic immune suppression.
- SOX10 promotes immune evasion in melanoma through PD-L1 expression.
Related Concept Videos
Pleiotropy
The Intrinsic Apoptotic Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The Extrinsic Apoptotic Pathway

